DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
Keyword(s):
T Cell
◽
2016 ◽
Vol 11
(6)
◽
pp. 593-600
◽
2019 ◽
Vol 13
◽
pp. 253-264
◽